New Republic Capital LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,951 shares of the healthcare conglomerate’s stock after acquiring an additional 51 shares during the period. New Republic Capital LLC’s holdings in UnitedHealth Group were worth $1,022,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently bought and sold shares of UNH. Geode Capital Management LLC lifted its stake in shares of UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock worth $10,068,869,000 after buying an additional 319,515 shares during the period. Capital International Investors lifted its stake in shares of UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock worth $7,899,905,000 after buying an additional 906,365 shares during the period. Northern Trust Corp lifted its stake in shares of UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock worth $4,807,527,000 after buying an additional 1,058,488 shares during the period. Franklin Resources Inc. lifted its stake in shares of UnitedHealth Group by 10.7% during the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock worth $4,514,178,000 after buying an additional 861,854 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock worth $4,346,712,000 after purchasing an additional 2,301,010 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on UNH. Bank of America cut shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Wolfe Research reduced their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a report on Tuesday, May 20th. Barclays reissued an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Baird R W cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 11th. Finally, Truist Financial cut their price objective on shares of UnitedHealth Group from $360.00 to $345.00 and set a “buy” rating for the company in a report on Wednesday, July 16th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $392.29.
Insider Buying and Selling
In other news, CFO John F. Rex bought 17,175 shares of the firm’s stock in a transaction on Friday, May 16th. The shares were bought at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the acquisition, the chief financial officer directly owned 203,796 shares of the company’s stock, valued at $59,329,091.52. This trade represents a 9.20% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders acquired a total of 109,408 shares of company stock worth $31,607,768 over the last ninety days. 0.28% of the stock is currently owned by insiders.
UnitedHealth Group Stock Performance
UNH opened at $280.69 on Monday. The firm has a market capitalization of $254.62 billion, a PE ratio of 11.75, a PEG ratio of 1.39 and a beta of 0.45. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The firm’s 50-day moving average price is $301.58 and its 200 day moving average price is $424.22. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.
UnitedHealth Group Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 3.15%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. UnitedHealth Group’s payout ratio is presently 37.02%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Which Wall Street Analysts are the Most Accurate?
- T-Mobile Earnings Show You Why This Is a Stock to Hold
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Bitcoin and Ethereum Surge: Here Are 5 Set to Ride the Wave
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- PEGA Surges 14%: There’s Still Time to Ride This GenAI Innovator
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.